Abacus Medicine Pharma Services provides tailored commercialisation solutions for rare disease medicines in European markets.
In partnering with developers of innovative therapies, we tailor bespoke commercialisation solutions to bring the next generation of rare disease treatments into European markets.
Combining decades of cross-functional industry expertise with the strong supply chain backbone of the Abacus Medicine Group, we offer true end-to-end commercialisation solutions to drive pan-European drug launches on our partners’ behalf.
Our Functional Areas
Contact the Commercial Partnerships team today
By combining decades of cross-functional industry experience with a resilient supply chain, we are in a position to deliver unique and impactful solutions in true partnership.
Case Study CP0001
Multi market EU launch, promotion and distribution.
Read our case study on how Abacus Medicine Pharma Services has developed a multi market access strategy for a client to successfully launch, promote, and distribute a rare disease product in 10 EU countries.
Case Study CP0002
Simplyfying medicine access and growth in the Nordics.
Read our case study on how Abacus Medicine Pharma Services has helped several clients identify a larger potential for sales growth and operational effectiveness.